Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1995-10-11
|
pubmed:abstractText |
P-glycoprotein (P-gly), which is responsible for the phenotypic expression of multidrug resistance in cancerous tissue was stained immunohistochemically in previously untreated alpha-fetoprotein (AFP)-producing (n = 20) and nonproducing gastric cancers (n = 20). P-gly, AFP, and carcinoembryonic antigen(CEA) were stained in formalin-fixed paraffin-embedded tissue sections immunohistochemically using the monoclonal antibody JSB-1, anti-AFP, and anti-CEA, respectively. DNA ploidy pattern was determined by Fluorescence Activated Cell Sorter (FACS) analyzer. P-gly was significantly overexpressed in AFP producing gastric cancers (60%) than in AFP nonproducing ones (20%) (P < 0.01). When the result of P-gly staining was analyzed among the AFP-positive cases, P-gly positivity did not emerge either as a significant prognostic factor or as a predictor of the metastatic potentiality of the tumor. The intrinsic overexpression of P-gly in AFP producing gastric cancers proves its biological and morphological similarities to hepatocellular carcinoma. The significantly (P < 0.05) higher incidence of P-gly in diploid tumors indicate that expression of this phenotype might be related to the differentiation of the tumor. P-gly was overexpressed in AFP producing gastric carcinoma and the existing drug resistance, frequent recurrence, and poor prognosis might be explained by presence of P-gly in this carcinoma.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0022-4790
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
60
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
50-4
|
pubmed:dateRevised |
2006-4-24
|
pubmed:meshHeading |
pubmed-meshheading:7545256-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7545256-Carcinoembryonic Antigen,
pubmed-meshheading:7545256-Carcinoma,
pubmed-meshheading:7545256-DNA, Neoplasm,
pubmed-meshheading:7545256-Drug Resistance, Multiple,
pubmed-meshheading:7545256-Flow Cytometry,
pubmed-meshheading:7545256-Humans,
pubmed-meshheading:7545256-P-Glycoprotein,
pubmed-meshheading:7545256-Paraffin Embedding,
pubmed-meshheading:7545256-Prognosis,
pubmed-meshheading:7545256-Staining and Labeling,
pubmed-meshheading:7545256-Stomach Neoplasms,
pubmed-meshheading:7545256-alpha-Fetoproteins
|
pubmed:year |
1995
|
pubmed:articleTitle |
Overexpression of P-glycoprotein in untreated AFP-producing gastric carcinoma.
|
pubmed:affiliation |
Second Department of Surgery, Shimane Medical University, Izumo, Japan.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|